Daily Archives: February 28, 2020

Vimizim Re-Evaluation Process Suspended

NICE¬†Statement We are writing to let you know that the re-evaluation of elosulfase alfa for treating mucopolysaccharidosis type IVa (review of HST2) [ID1643] is now suspended. This is because the company has not provided an evidence submission that is adequate for the committee to make a decision, and will not accept the terms of the […]